CIDRAP newsletters options
As researchers work on solving the complex puzzle of all the factors that influence flu vaccine effectiveness (VE), researchers today report that low VE of the H3N2 component during the 2012-13 flu season may have been due to poor immune response rather than adaptations in egg-grown vaccine viruses, as previously thought.
CARB-X, a public-private collaboration that supports companies in early-stage antibiotic discovery and development, recently announced its first funding award for 2018 and provided details about two funding rounds for the current year.
Brazil has confirmed almost 1,000 human cases since July 2016, and cases in animals have doubled.
The proposed law would direct $200 million a year for 5 years to research.
The Saudi Arabian Ministry of Health (MOH) confirmed one new case of MERS-CoV on Feb 17. The MOH has issued only sporadic updates this month, and this is the second update in 3 weeks.
A 74-year-old Saudi woman from Rafha was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). She is in stable condition. The probable source of her infection is indirect contact with camels, a likely risk factor for the virus.
The rate of ILI clinic visits drops slightly, but 22 new deaths in kids show the season is not relenting.
IDSA/SHEA guidelines recommend fecal microbiota transplantation for patients with multiple recurrences.
An investigation into an outbreak involving Salmonella Heidelberg infections linked to dairy cows is over, according to an announcement today from the Centers for Disease Control and Prevention (CDC).
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In patients hospitalized with serious infections from carbapenem-resistant gram-negative bacteria, a combination of colistin and meropenem wasn't associated with fewer clinical failures compared with colistin alone, researchers reported today in The Lancet Infectious Diseases.
Protection is 36% overall, 25% against H3N2, 67% against H1N1, and 42% against flu B.
H9N2 avian flu typically circulates in birds as a low-pathogenic strain.
The Centers for Disease Control and Prevention (CDC) said today that a multistate Salmonella outbreak—first announced a month ago—appears to be over after it reached 27 cases in nine states.
The high-dose flu vaccine is 38% more effective in protecting elderly people against laboratory-confirmed influenza than the standard-dose vaccine, according to a study of Veterans Health Administration (VHA) senior patients published yesterday in the Journal of Infectious Diseases.
Even an epidemic in a far-off country could do major damage to the US economy, experts say.
Low-income nations have a 60% higher risk of infection.
China has reported the world's first known novel H7N4 avian flu infection in a human, according to a report today from Hong Kong's Centre for Health Protection (CHP), which based its information on a notification from the mainland's National Health and Family Planning Commission.
Italian scientists this week reported detecting the MCR-1 colistin-resistance gene in 26 Escherichia coli isolates among more than 19,000 Enterobacteriaceae that they tested as part of surveillance efforts in Romagna in northern Italy.
A probe of child flu deaths over 6 seasons found vaccination gaps and a somber reminder that even healthy kids can succumb.
The newly identified molecules, called malacidins, are linked to a family of antibiotics that require calcium for antibacterial activity.
